Logo.PNG
Veritas leads Puerto Rico partnership with approval of new Investigation License
11 févr. 2019 12h19 HE | Veritas Pharma Inc.
SAN JUAN, Puerto Rico, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma, Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”),...
Logo.PNG
Veritas Pharma to Proceed with Share Consolidation
04 févr. 2019 19h37 HE | Veritas Pharma Inc.
VANCOUVER, British Columbia, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it is proceeding with a...
Logo.PNG
Veritas Pharma Signs MOU with Santa Marta Gold Holdings for a Medical Cannabis Research Collaboration
15 janv. 2019 09h00 HE | Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered...
Logo.PNG
Veritas Pharma Makes Strategic Investment in Cannabis Production for Future Cannevert R&D Needs
21 déc. 2018 09h37 HE | Veritas Pharma Inc.
VANCOUVER, British Columbia, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that the Company has...
Logo.PNG
Veritas Appoints Corporate Secretary & CFO; and Issues Stock Options
20 déc. 2018 18h08 HE | Veritas Pharma Inc.
VANCOUVER, British Columbia, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce the appointment of...
Logo.PNG
Veritas Announces Binding Share Purchase Agreement with Leis Industries Limited for Sale of Sechelt Organic Marijuana
14 nov. 2018 08h15 HE | Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered...
Logo.PNG
Veritas Confirms Readiness for Human Trials of CTL-X for Pain; Projected to Start Early Next Month
08 nov. 2018 08h30 HE | Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that, despite the...
Logo.PNG
Veritas Announces First Closing of Financing
06 nov. 2018 12h13 HE | Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce the Closing of the...
Logo.PNG
Veritas Announces Investment Into Cannabis Growing Facility Under Health Canada License
23 oct. 2018 08h15 HE | Veritas Pharma Inc.
VANCOUVER, British Columbia, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce a $1.25 million...
Logo.PNG
Veritas Pharma Attending CannX International Medical Cannabis Conference in Tel Aviv, Israel
11 oct. 2018 17h55 HE | Veritas Pharma Inc.
VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that its CEO Dr. Lui...